Clinical Trials on Glabellar Crease
Total 10000 results
-
Espad PharmedCenter for Research and Training in Skin Diseases and LeprosyCompletedGlabellar Frown Lines | Glabellar LinesIran, Islamic Republic of
-
HugelRecruitingGlabellar LinesKorea, Republic of
-
Eirion Therapeutics Inc.Active, not recruiting
-
AllerganCompleted
-
Galderma R&DCompleted
-
AbbVieCompletedGlabellar LinesChina, Japan, Taiwan
-
AbbVieCompletedGlabellar LinesUnited States, Canada, Germany, Hungary, Poland
-
AllerganCompleted
-
IpsenCompletedGlabellar LinesFrance, Germany, United Kingdom
-
BMI KoreaCompletedGlabellar LinesKorea, Republic of
-
IpsenCompletedGlabellar LinesAustralia, Brazil, Czechia, Kazakhstan, Lebanon, Russian Federation, Turkey, Ukraine
-
Mentor Worldwide, LLCSynteract, Inc.CompletedGlabellar RhytidesUnited States
-
AbbVieCompleted
-
AbbVieCompleted
-
Daewoong Pharmaceutical Co. LTD.CompletedGlabellar LinesKorea, Republic of
-
Medy-ToxCompletedGlabellar LinesUnited States, Belgium, Russian Federation
-
CKD Bio CorporationCompletedGlabellar LinesKorea, Republic of
-
IpsenCompleted
-
Oregon Health and Science UniversityAllerganCompletedGlabellar Furrows
-
AllerganCompletedGlabellar LinesGermany
-
Huons Co., Ltd.CompletedGlabellar LinesKorea, Republic of
-
GlaxoSmithKlineCompleted
-
Advanced Cosmetic InterventionCompletedGlabellar FurrowingUnited States, Canada
-
Protox Inc.CompletedGlabellar Frown LinesKorea, Republic of
-
Protox Inc.CompletedGlabellar Frown LinesKorea, Republic of
-
Medytox KoreaCompletedGlabellar Frown LinesKorea, Republic of
-
IpsenCompleted
-
Revance Therapeutics, Inc.CompletedEfficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar LinesGlabellar Frown LinesUnited States, Canada
-
Medy-ToxCompletedGlabellar Frown LinesAustralia
-
ATGC Co., Ltd.CompletedGlabellar Frown LinesKorea, Republic of
-
Evolus, Inc.PPDCompletedGlabellar Frown LinesUnited States
-
Evolus, Inc.CompletedGlabellar Frown LinesUnited States
-
Evolus, Inc.PPDCompletedGlabellar Frown LinesUnited States
-
Evolus, Inc.PPDCompletedA Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV001Glabellar Frown LinesUnited States
-
Revance Therapeutics, Inc.CompletedGlabellar Frown LinesCanada
-
AllerganCompletedGlabellar Frown LinesUnited States
-
Merz Pharmaceuticals GmbHCompletedGlabellar Frown LinesUnited Kingdom, Germany, Austria
-
ATGC Co., Ltd.RecruitingGlabellar Frown LinesKorea, Republic of
-
Revance Therapeutics, Inc.CompletedGlabellar Frown LinesUnited States
-
Galderma R&DCompletedGlabellar Frown LinesUnited States
-
Medy-ToxCompletedGlabellar Frown LinesAustralia
-
Galderma R&DCompletedGlabellar Frown LinesUnited States
-
Galderma R&DCompleted
-
Revance Therapeutics, Inc.CompletedEfficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar LinesGlabellar Frown LinesUnited States
-
Revance Therapeutics, Inc.CompletedGlabellar Frown LinesUnited States, Canada
-
Medytox KoreaCompletedGlabellar Frown LinesKorea, Republic of
-
Protox Inc.CompletedGlabellar Frown LinesKorea, Republic of
-
Medy-ToxCompletedGlabellar Frown LinesKorea, Republic of
-
Medy-ToxCompletedGlabellar Frown LinesRussian Federation